Search

Betnovate

Betnovate

betamethasone

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Betamethasone-17-valerate
Indications/Uses
Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses eg, atopic, nummular, seborrhoeic, irritant or allergic contact dermatitis; prurigo nodularis, psoriasis, lichen simplex chronicus & planus, discoid lupus erythematosus, insect bite reactions, miliara. Adjunct to systemic steroid therapy in generalised erythroderma.
Click to view Betnovate detailed prescribing information
Dosage/Direction for Use
Adult, elderly & childn >1 yr Apply thinly to affected area once or bd for up to 4 wk. Patient who frequently relapse Reduce to once daily twice wkly.
Click to view Betnovate detailed prescribing information
Overdosage
View Betnovate overdosage for action to be taken in the event of an overdose.
Contraindications
Untreated cutaneous infection, rosacea, acne vulgaris, pruritus w/o inflammation, perioral dermatitis, perianal & genital pruritus. Dermatoses in infants <1 yr including dermatitis.
Click to view Betnovate detailed prescribing information
Special Precautions
Hypersensitivity to corticosteroids. Cushing's syndrome & reversible hypothalamic-pituitary-adrenal axis suppression. Increased risk of systemic effects. Concomitant infection. Psoriasis, chronic leg ulcers; visual disturbances. Use w/ occlusive dressings. Prolonged use. Avoid contact w/ face & eyes. Avoid abrupt w/drawal. Renal or hepatic impairment. Pregnancy & lactation. Avoid long-term continuous therapy in infants & childn <12 yr. Elderly.
Click to view Betnovate detailed prescribing information
Adverse Reactions
Pruritus, local skin burning/skin pain.
Click to view Betnovate detailed prescribing information
Drug Interactions
Inhibited metabolism by CYP3A4 inhibitors eg, ritonavir, itraconazole.
Click to view Betnovate detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Betnovate detailed prescribing information
Storage
View Betnovate storage conditions for details to ensure optimal shelf-life.
Description
View Betnovate description for details of the chemical structure and excipients (inactive components).
Action
View Betnovate mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Topical Corticosteroids
ATC Classification
D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Betnovate cream 0.1%
Packing/Price
100 g x 1's;15 g x 1's (RM19.05/tube)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in